Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152187 | SCV000200926 | uncertain significance | not specified | 2014-03-14 | criteria provided, single submitter | clinical testing | The Arg28674His variant in TTN has not been reported in individuals with cardiom yopathy, but has been identified in 1/8312 European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. Additional information is needed to fully ass ess the clinical significance of the Arg28674His variant. |
Gene |
RCV001704095 | SCV000237779 | likely benign | not provided | 2019-11-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27930701) |
Ambry Genetics | RCV002362797 | SCV002663826 | likely benign | Cardiovascular phenotype | 2020-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001704095 | SCV003820337 | uncertain significance | not provided | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704095 | SCV004150227 | uncertain significance | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing |